Navigation Links
Study Showed Minimally Invasive Surgery Reduced Risk of Hospital-Acquired Infections Compared to Open Surgery
Date:4/10/2008

PHILADELPHIA, April 10 /PRNewswire/ -- SAGES 2008 ANNUAL MEETING - Ethicon Endo-Surgery today announced results from a new study showing laparoscopic surgery reduced the risk of nosocomial (hospital-acquired) infections by 52 percent when compared to open surgery in a sample of more than 11,000 patients undergoing one of the following three surgical procedures: hysterectomy, cholecystectomy (gallbladder removal) and appendectomy. Specific to individual surgeries, the study found laparoscopic surgery was associated with reduction of the risk of nosocomial infections during gallbladder removal by 66 percent, and during hysterectomy by 52 percent compared to open surgery. The study showed the reduction rates of nosocomial infections during laparoscopic appendectomy were not statistically significant.

The results of the study will be presented on April 12, 2008 at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting. The data also will be published in the April edition of Surgical Endoscopy, the official journal of SAGES.

The study, sponsored by Ethicon Endo-Surgery entitled "The Effects of Laparoscopic Cholecystectomy, Hysterectomy, and Appendectomy on Nosocomial Infection Risks," is the first to examine infections specific to these procedures 30 days post-discharge, providing a more comprehensive picture of infection patterns than previously available. The study discovered 40 percent of the infections identified occurred within 30 days after hospital discharge.

Results of the study also showed laparoscopic surgery was associated with a reduction in the overall odds ratio for each type of nosocomial infection. Compared to open surgery, patients in the study who underwent laparoscopic surgery experienced 80 percent reduction in the odds of respiratory tract infection, 69 percent reduction in bloodstream infection, 59 percent reduction in wound infection, 39 percent reduction in urinary tract infection and a 48 percent reduction in other types of nosocomial infections across hysterectomies, cholecystectomies and appendectomies.

In addition to the potential patient benefits due to reduced infection, there are cost implications of the study, as well. The study found that 27 percent of patients identified with a post-discharge infection were re-admitted to the hospital, which is an added cost for hospitals and payors. However, there was a 65 percent reduction in hospital readmissions for hospital-acquired infections when a patient underwent laparoscopic gallbladder removal and hysterectomy when compared to open surgery.

"This study gives more definitive evidence that laparoscopic surgery reduces the risk of nosocomial infection compared to open surgery, which may lead to improved patient care and potential reductions in costs to the healthcare system, " said Andrew I. Brill, M.D., Director of Minimally Invasive Gynecology, California Pacific Medical Center, San Francisco, one of the lead investigators for the study.

The retrospective study covered more than 11,000 patients for the period September 1, 2004 through December 31, 2006 from 22 hospitals across 15 states that had undergone laparoscopic or open hysterectomy (43.3 percent of patients), gallbladder removal (32.7 percent of patients) and appendectomy (24 percent of patients). In the current study, 337 patients (2.89 percent) experienced at least one nosocomial infection. Overall, infection rates were nearly twice as high for open procedures (4.09 percent) than for laparoscopic procedures (2.11 percent). The study utilized the Nosocomial Infection Marker (NIM), an algorithm designed by Cardinal Health that monitors and tracks nosocomial infection rates for up to 30 days post-discharge. In a previous multi-hospital study, the NIM algorithm identified nosocomial infections with 86 percent sensitivity and 98.5 percent specificity, statistically outperforming CDC case finding methods.(1)

"This study demonstrates the significant impact minimally-invasive technology can have on patient care and health care cost-saving," said Andrew Webber, president and CEO, National Business Coalition on Health, a non-profit, membership association of 60 business and health coalitions, representing a national network of 7,000 employers and 34 million covered lives. "As adoption rates for laparoscopic surgery continue to grow, both patients and the employers who pay for the bulk of health care may benefit from improved quality of care and reduced costs as patients could possibly realize shorter hospital stays and reduced potential complications."

About Ethicon Endo-Surgery

Ethicon Endo-Surgery, a Johnson & Johnson company, develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. More information can be found at http://www.ethiconendo.com .

(1) Brossette SE, Hacek DM, Gavin PJ, et al. A laboratory-based,

hospital-wide, electronic marker for nosocomial infections: the future

of infection control surveillance? Am J Clin Pathol 2006; 125:34-39.


'/>"/>
SOURCE Ethicon Endo-Surgery
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NEJM study demonstrates carotid stenting with embolic protection is comparable to surgery
2. Egg Consumption Poses Risks for Diabetic Men: Study
3. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
4. Landmark Study Aims to Improve Osteoporosis Care Standards Worldwide
5. Forecasting MDs prescriptions choice? Ask their patients, says Management Insights study
6. Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption
7. Best Practices, LLC Announces New Benchmarking Study - How World-Class Companies Proactively Manage Competitors
8. Study: Health shocks diminish wealth more later in life
9. Study sheds light on link between sleep disorder, behavior issues in kids
10. Award-winning study says back pain may be in your genes
11. 2004 long-term care act raised costs and worsened care, study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... 05, 2016 , ... Francisco Canales, MD and Heather Furnas, ... Valley office. The technique utilizes the body’s own healing abilities to quickly rejuvenate ... are part of only a select few cosmetic surgeons bringing this procedure to ...
(Date:2/5/2016)... ... February 05, 2016 , ... After years as an active ... Unit, plastic and cosmetic surgeon Dr. Wayne Carman transitioned to chief of the Division ... completed his first three-year term as chief and began a second three-year term in ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... PROSHRED franchises from across the country gathered at the La Valencia Hotel in ... performers. PROSHRED Chicago was named the year’s most outstanding franchise, walking away ...
(Date:2/5/2016)... ... 05, 2016 , ... Give To Cure today announced that it ... to Give To Cure’s campaign that is crowdfunding clinical trials to help find cures ... payments through a smart device. In 2015 alone, Venmo processed $7.5 billion in transactions ...
(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held ... as Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, ... stated Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Feb. 5, 2016 Aethlon Medical, Inc. (Nasdaq: ... and CEO, will be presenting at Source Capital Group,s 2016 ... NY at 2:15 p.m. ET on Wednesday, February ... Panel discussion taking place at 3:15 p.m. ET. ... one hour after the conclusion of the live event. The ...
(Date:2/5/2016)... , February 5, 2016 ... Market Research report states that the global active pharmaceuticals ... and is predicted to reach US$185.9 bn by 2020. ... 6.50% from 2014 to 2020. The title of the ... Captive/Contract Manufactured, by Geography, and by Therapeutic Area) - ...
(Date:2/5/2016)... , Feb. 5, 2016  Zimmer Biomet Holdings, Inc. ... the previously announced underwritten secondary offering of 11,027,558 shares ... consisting of affiliates of Blackstone and Goldman Sachs.  The ... initial price of $96.45 per share. The selling stockholders ...  Neither Zimmer Biomet nor any of its directors, officers ...
Breaking Medicine Technology: